Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcoma: the European Organisation for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (STBSG) and French Sarcoma Group (FSG) study - Penel, Nicolas; Glabbeke, M. V.; Mathoulin-Pelissier, S.; Judson, I.; Sleijfer, S.; Bui, B.; Schoffski, P.; Ouali, M.; Marreaud, S.; Brouste, V.; Duhamel, A.; Hohenberger, Peter; et al. (British journal of cancer, 2011)
Gesehen am 19.10.2022